Advance Health Mobile APP for the Self Management of Diabetes Type2

Not Applicable

Not yet recruiting

Brief Summary: Digital health using mobile health (mHealth) tools, such as telehealth and text messaging, and or mobile Apps can improve blood glucose levels in patients with type 2 diabetes. This intervention is designed to improve self-management of diabetes and blood glucose levels in diabetic patients.

Detailed Description: Patients with type 2 diabetes may experience improvements in their blood glucose levels thanks to mHealth technologies like mobile apps and telehealth text messaging. The goal of this intervention is to help diabetic people better control their blood glucose levels and diabetes. The intervention arm will employ a smartphone application designed specifically for individuals with Type 2 diabetes, with the goal of improving their self-management behaviors. Features of the app include real-time health monitoring, appointment scheduling, medication tracking, patient data storage, treatment and follow-up recommendations, and health education and promotion.

Recruitment & Eligibility

Inclusion Criteria

The presence of T2D and at least 1 recorded HbA1c level of 8.0% or higher in the past 6 months
Age between ages 21 and 85 years,
Receiving primary care at the clinical site
Having fluency in English/ Urdu in reading and writing
Having a smartphone
Agreeing to take part in the study

Exclusion Criteria

Planning to move away from the study site
Being pregnant or in lactation, (6) being unable to send or read text messages on a mobile phone,
Having a history of receiving or planning surgery.

Arm && Interventions

Group	Intervention	Description
Intervention arm	Diabetes self management @ click	Ae mobile application tailored for patients with Type 2 diabetes, aiming to enhance their self-management practices will be used for the intervention arm. The app includes features such as medication tracking, appointment scheduling, patient data storage, advice for treatment and follow-ups, health education and promotion, and real-time health monitoring.

Primary Outcome Measures

Name	Time	Method
Diabetes Self-Management	6- months from baseline	DSMQ-R will assess Diabetes self-management. The DSMQ-R is a multidimensional questionnaire with 27 items regarding essential self-management practices for T1D and T2D (including diabetes-adjusted eating, glucose testing/monitoring, medication taking, physical activity, and cooperation with the diabetes team). 4 Subscales: * 'Glucose Management' (GM), 11 items: 1, 4, 6, 10, 12, 21, 22, 23, 24, 26, 27 (10 and 12 must be inverted). * 'Dietary Control' (DC), 7 items: 2, 5, 9, 13, 17, 18, 25 (5, 13 and 18 must be inverted). * 'Physical Activity' (PA), 3 items: 8, 11, 15 (11 and 15 must be inverted). * 'Health-Care Use' (HU), 4 items: 3, 7, 14, 19 (7 and 14 must be inverted). SCALE SCORE = ACTUAL SUM OF ITEMS / MAXIMUM POSSIBLE SUM OF ITEMS x 10

Secondary Outcome Measures

Name	Time	Method
Hemoglobin A1C	6- months from baseline	Hemoglobin A1C will be measured by taking blood samples.
Adherence to medication	6- months from baseline	SEAMS URDU VERSION WILL BE USED FOR SEAMS Urdu version. It is of 13 questions with a score ranging from 13-39. Higher scores show better adherence
Health related quality of life	6- months from baseline	Health-related quality of life will be assessed by EQ 5D3L. The EQ-5D-3L Index score summarizes each possible health state on a numerical scale ranging from -0.594 to 1, where a score of 1 indicates full health and scores of 0 and less than 0 indicate a state equivalent to being dead, and a state

Receive instant email notifications about changes in this clinical trial

Receive instant email notifications about changes in this clinical trial